Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)
Hong Kong · Delayed Price · Currency is HKD 81.05
-2.00 (-2.41%)
At close: Feb 13, 2026
HKG:6821 Market Cap
HKG:6821 has a market cap or net worth of 40.03 billion as of February 13, 2026. Its market cap has increased by 48.48% in one year.
Market Cap
40.03B
Enterprise Value
31.48B
Revenue
6.88B
Ranking
n/a
PE Ratio
35.26
Stock Price
81.05
Market Cap Chart
Since November 18, 2016, HKG:6821's market cap has increased from 5.59B to 40.03B, an increase of 616.01%. That is a compound annual growth rate of 23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 40.07B | 10.43% |
| Dec 31, 2025 | 36.28B | 29.95% |
| Dec 31, 2024 | 27.92B | -38.76% |
| Dec 29, 2023 | 45.59B | -23.48% |
| Dec 30, 2022 | 59.58B | -56.36% |
| Dec 31, 2021 | 136.53B | 58.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 58.54B |
| RemeGen | 58.02B |
| Shanghai Henlius Biotech | 38.23B |
| Shanghai Junshi Biosciences | 35.29B |
| Biocytogen Pharmaceuticals (Beijing) | 34.71B |
| Duality Biotherapeutics | 30.29B |
| TransThera Sciences (Nanjing) | 27.89B |
| Genscript Biotech | 27.05B |